Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.

The two‐period cross‐over clinical trial.

1979 • 1,402 citations

Plasma norepinephrine in congestive heart failure

1978 • 919 citations

Statistical guidelines for contributors to medical journals.

1983 • 648 citations

Increased plasma arginine vasopressin levels in patients with congestive heart failure

1983 • 481 citations

A sensitive radioenzymatic assay for norepinephrine in tissues and plasma

1975 • 475 citations

Long-term therapy of heart failure with prazosin: A randomized double blind trial

1980 • 183 citations

Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.

1981 • 179 citations

Renin relationships in congestive cardiac failure, treated and untreated

1970 • 176 citations

Neurohumoral control mechanisms in congestive heart failure

1981 • 169 citations

Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous system

1982 • 133 citations

Hemodynamic Characterization of Tolerance to Long-Term Hydralazine Therapy in Severe Chronic Heart Failure

1982 • 101 citations

Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapy.

1981 • 98 citations

Cerebral blood flow in patients with congestive heart failure treated with captopril

1984 • 93 citations

The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: Response to specific inhibitors (prazosin and captopril)

1982 • 92 citations

The effect of intracerebroventricular injections of morphine on vasopressin release in the rat.

1981 • 80 citations

Measurement of plasma renin activity by radioimmunoassay after prolonged cold storage

1978 • 74 citations

Results of long-term vasodilator therapy in patients with refractory congestive heart failure.

1981 • 74 citations

Vasodilator treatment for acute and chronic heart failure.

1977 • 68 citations

Increased Plasma Norepinephrine Levels During Prazosin Therapy for Severe Congestive Heart Failure

1980 • 58 citations

Determination of the vasodilator UK33274 by high-performance liquid chromatography using fluorescence detection

1980 • 45 citations

Acute hemodynamic responses to vasodilator therapy in congestive heart failure

1982 • 36 citations

Prazosin and congestive heart failure: Short- and long-term therapy

1981 • 35 citations

Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure

1981 • 33 citations

Bedside haemodynamic monitoring: experience in a general hospital.

1983 • 30 citations

Clinical, hemodynamic, and neuroendocrine effects of chronic prazosin therapy for congestive heart failure

1981 • 28 citations

Oral vasodilator therapy with prazosin in severe congestive heart failure

1981 • 19 citations

Immediate and sustained haemodynamic effects of prazosin during upright exercise in man.

1981 • 18 citations

Limiting Symptoms in Chronic Heart Failure Are Dependent on Rate of Increase of Work Load and Independent of Haemodynamics

1984 • 3 citations